Monday, December 16, 2019

Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis by JAN HOFFMAN and DANNY HAKIM


By JAN HOFFMAN and DANNY HAKIM

A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.

Published: December 15, 2019 at 07:00PM

from NYT Health https://ift.tt/35taG0z
via IFTTT



from WordPress https://ift.tt/38UgKl4
via IFTTT

No comments:

Post a Comment